flatfish
01-04-2007, 05:21 PM
CALENDAR 2007 (03): 11TH ANNUAL TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES
MEETING
***********************************************
A ProMED-mail post
<http://www.promedmail.org>
ProMED-mail is a program of the
International Society for Infectious Diseases
<http://www.isid.org>
Date: Thu 4 Jan 2007
From: ProMED-mail<promed@promedmail.org>
Subject: Cambridge Healthtech Institute's 11th Annual "Transmissible
Spongiform Encephalopathies"
Location: Baltimore, Maryland, USA
Venue: Baltimore Marriott Inner Harbor
Dates: 12-13 Feb 2007
The Definitive American TSE Meeting
* Advanced Registration Deadline is 12 Jan. Register Now & Save up to
$200! <https://commerce22.datapipe.com/chidb/2007/tse/reg.asp>
* to download PDF brochure go to <http://www.healthtech.com/2007/tse/pdf.asp>
* Display a Poster and Save an Additional $50 Off Your Registration
Transmissible Spongiform Encephalopathies continue to cause serious concern
among researchers whose work utilizes materials from animals and/or humans
which may be contaminated with the causative agent. The appearance of BSE
in herds of cattle born after the introduction of the ruminant feed ban and
the potential impact of BSE and CWD on human health in the U.S has raised
new concerns and questions, as has the continued occurrence of Chronic
Wasting Disease (CWD) in North American deer herds. The news that 3 of 17
recipients of blood from a vCJD donor contracted the disease has shown that
transmission through blood transfusion is a reality. This conference will
present the newest data on TSE's in the context of its application to the
pharmaceutical, biological, environmental and device industries.
Agenda
Monday, 12 Feb 2007
EMERGING CONCERNS
Variant CJD: The End of the Beginning or the Beginning of the End?
Robert G. Will, M.D., National CJD Surveillance Unit, University of Edinburgh
Sporadic CJD: Does Transmission through Blood Occur?
Maurizio Pocchiari, Ph.D., Director of Research-Virology, Istituto
Superiore Di Sanita (Italy)
The 'Spontaneous' BSE Issue: Pros, Cons, and Strategies to Test the Hypothesis
Paul W. Brown, M.D.
Discrimination between CWD, BSE and Scrapie Strains: An Evaluation of Tests
Michael Stack, Senior Researcher, TSE Molecular Biology, Veterinary
Laboratories Agency
NEW RESEARCH DIRECTIONS
Developing Cell Cultures for Prion Studies
Sylvain Lehmann, Professor, Institut de Genetique Humaine du CNRS
Retroviral Infection Strongly Enhances the Release of Scrapie Infectivity
in Cell Culture
Pascal LeBlanc, Ph.D., LaboRetro unite de virologie humaine, INSERM
INFECTIVITY AND TRANSMISSION
Infectivity in Urine of Hamsters Infected with Scrapie
Luisa Gregori, Ph.D., Assistant Director and Assistant Professor, VA
Research Services
and University of Maryland, BREF
Soil Minerals Enhance Prion Infectivity
Judd M. Aiken, DVM, Professor, Animal Health & Biomedical Sciences,
University of
Wisconsin-Madison, School of Veterinary Medicine
Transmission of BSE-301v Following Infection from the Small Intestine: A
New Model for Investigating Iatrogenic Transmission Risks for vCJD
James Walker, Ph.D., Senior Project Manager, TSE Research Group, Health
Protection Agency
Transmission of the Italian Atypical BSE (BASE) in Humanized Mouse Models
Qingzhong Kong, Ph.D., Assistant Professor, Pathology, Case Western Reserve
University
Tuesday, February 13
DETECTION AND REMOVAL
Prion Strain Identification by the Scrapie Cell Assay using Cell Panels
Sukhi Mahal, Ph.D. and Charles Weissmann, Ph.D., Department of Infectology,
Scripps Florida
Detection of PrPsc in Sheep Plasma using SRA
Seong An, Ph.D., Research Fellow, Research and Development, PeopleBio Inc.
Update on the 15B3 CJD Blood Test
Alex Raeber, Ph.D., Director of Research, Prionics AG
Detection and Removal of Residual Contamination on Surgical Instruments
Helen Baxter, Ph.D., Senior University Fellow, School of Chemistry,
University of Edinburgh
CONFORMATIONAL TRANSITION AND INFECTIVITY
Characterization of PrP-Derived Peptides Capable of Discriminating between
and PrPSc in Plasma
Anthony L. Lau, Ph.D., Post-Doctoral Fellow, Novartis Vaccines and
Diagnostics, Inc.
Abnormal Prion Protein Conformers in Normal Human Brain
Wen-Quan Zou, M.D., Ph.D., Assistant Professor, Pathology, Case Western
Reserve University
Controlling Amyloid Growth in all Dimensions
David G. Lynn, Ph.D., Center for the Analysis of Supramolecular
Self-assemblies, Center for Neurodegenerative Diseases, Departments of
Chemistry and Biology, Emory University
Register by 12 Jan 2007 and Save up to $200
View full conference details at <http://www.healthtech.com/2007/TSE> or
call Cambridge Healthtech Institute at 781-972-5400 or toll-free in the
U.S. 888-999-6288.
--
ProMED-mail
<promed@promedmail.org>
........lm/pg/dk
*################################################# #########*
************************************************** **********
ProMED-mail makes every effort to verify the reports that
are posted, but the accuracy and completeness of the
information, and of any statements or opinions based
thereon, are not guaranteed. The reader assumes all risks in
using information posted or archived by ProMED-mail. ISID
and its associated service providers shall not be held
responsible for errors or omissions or held liable for any
damages incurred as a result of use or reliance upon posted
or archived material.
************************************************** **********
Become a ProMED-mail Premium Subscriber at
<http://www.isid.org/ProMEDMail_Premium.shtml>
************************************************** **********
Visit ProMED-mail's web site at <http://www.promedmail.org>.
Send all items for posting to: promed@promedmail.org
(NOT to an individual moderator). If you do not give your
full name and affiliation, it may not be posted. Send
commands to subscribe/unsubscribe, get archives, help,
etc. to: majordomo@promedmail.org. For assistance from a
human being send mail to: owner-promed@promedmail.org.
################################################## ##########
################################################## ##########
MEETING
***********************************************
A ProMED-mail post
<http://www.promedmail.org>
ProMED-mail is a program of the
International Society for Infectious Diseases
<http://www.isid.org>
Date: Thu 4 Jan 2007
From: ProMED-mail<promed@promedmail.org>
Subject: Cambridge Healthtech Institute's 11th Annual "Transmissible
Spongiform Encephalopathies"
Location: Baltimore, Maryland, USA
Venue: Baltimore Marriott Inner Harbor
Dates: 12-13 Feb 2007
The Definitive American TSE Meeting
* Advanced Registration Deadline is 12 Jan. Register Now & Save up to
$200! <https://commerce22.datapipe.com/chidb/2007/tse/reg.asp>
* to download PDF brochure go to <http://www.healthtech.com/2007/tse/pdf.asp>
* Display a Poster and Save an Additional $50 Off Your Registration
Transmissible Spongiform Encephalopathies continue to cause serious concern
among researchers whose work utilizes materials from animals and/or humans
which may be contaminated with the causative agent. The appearance of BSE
in herds of cattle born after the introduction of the ruminant feed ban and
the potential impact of BSE and CWD on human health in the U.S has raised
new concerns and questions, as has the continued occurrence of Chronic
Wasting Disease (CWD) in North American deer herds. The news that 3 of 17
recipients of blood from a vCJD donor contracted the disease has shown that
transmission through blood transfusion is a reality. This conference will
present the newest data on TSE's in the context of its application to the
pharmaceutical, biological, environmental and device industries.
Agenda
Monday, 12 Feb 2007
EMERGING CONCERNS
Variant CJD: The End of the Beginning or the Beginning of the End?
Robert G. Will, M.D., National CJD Surveillance Unit, University of Edinburgh
Sporadic CJD: Does Transmission through Blood Occur?
Maurizio Pocchiari, Ph.D., Director of Research-Virology, Istituto
Superiore Di Sanita (Italy)
The 'Spontaneous' BSE Issue: Pros, Cons, and Strategies to Test the Hypothesis
Paul W. Brown, M.D.
Discrimination between CWD, BSE and Scrapie Strains: An Evaluation of Tests
Michael Stack, Senior Researcher, TSE Molecular Biology, Veterinary
Laboratories Agency
NEW RESEARCH DIRECTIONS
Developing Cell Cultures for Prion Studies
Sylvain Lehmann, Professor, Institut de Genetique Humaine du CNRS
Retroviral Infection Strongly Enhances the Release of Scrapie Infectivity
in Cell Culture
Pascal LeBlanc, Ph.D., LaboRetro unite de virologie humaine, INSERM
INFECTIVITY AND TRANSMISSION
Infectivity in Urine of Hamsters Infected with Scrapie
Luisa Gregori, Ph.D., Assistant Director and Assistant Professor, VA
Research Services
and University of Maryland, BREF
Soil Minerals Enhance Prion Infectivity
Judd M. Aiken, DVM, Professor, Animal Health & Biomedical Sciences,
University of
Wisconsin-Madison, School of Veterinary Medicine
Transmission of BSE-301v Following Infection from the Small Intestine: A
New Model for Investigating Iatrogenic Transmission Risks for vCJD
James Walker, Ph.D., Senior Project Manager, TSE Research Group, Health
Protection Agency
Transmission of the Italian Atypical BSE (BASE) in Humanized Mouse Models
Qingzhong Kong, Ph.D., Assistant Professor, Pathology, Case Western Reserve
University
Tuesday, February 13
DETECTION AND REMOVAL
Prion Strain Identification by the Scrapie Cell Assay using Cell Panels
Sukhi Mahal, Ph.D. and Charles Weissmann, Ph.D., Department of Infectology,
Scripps Florida
Detection of PrPsc in Sheep Plasma using SRA
Seong An, Ph.D., Research Fellow, Research and Development, PeopleBio Inc.
Update on the 15B3 CJD Blood Test
Alex Raeber, Ph.D., Director of Research, Prionics AG
Detection and Removal of Residual Contamination on Surgical Instruments
Helen Baxter, Ph.D., Senior University Fellow, School of Chemistry,
University of Edinburgh
CONFORMATIONAL TRANSITION AND INFECTIVITY
Characterization of PrP-Derived Peptides Capable of Discriminating between
and PrPSc in Plasma
Anthony L. Lau, Ph.D., Post-Doctoral Fellow, Novartis Vaccines and
Diagnostics, Inc.
Abnormal Prion Protein Conformers in Normal Human Brain
Wen-Quan Zou, M.D., Ph.D., Assistant Professor, Pathology, Case Western
Reserve University
Controlling Amyloid Growth in all Dimensions
David G. Lynn, Ph.D., Center for the Analysis of Supramolecular
Self-assemblies, Center for Neurodegenerative Diseases, Departments of
Chemistry and Biology, Emory University
Register by 12 Jan 2007 and Save up to $200
View full conference details at <http://www.healthtech.com/2007/TSE> or
call Cambridge Healthtech Institute at 781-972-5400 or toll-free in the
U.S. 888-999-6288.
--
ProMED-mail
<promed@promedmail.org>
........lm/pg/dk
*################################################# #########*
************************************************** **********
ProMED-mail makes every effort to verify the reports that
are posted, but the accuracy and completeness of the
information, and of any statements or opinions based
thereon, are not guaranteed. The reader assumes all risks in
using information posted or archived by ProMED-mail. ISID
and its associated service providers shall not be held
responsible for errors or omissions or held liable for any
damages incurred as a result of use or reliance upon posted
or archived material.
************************************************** **********
Become a ProMED-mail Premium Subscriber at
<http://www.isid.org/ProMEDMail_Premium.shtml>
************************************************** **********
Visit ProMED-mail's web site at <http://www.promedmail.org>.
Send all items for posting to: promed@promedmail.org
(NOT to an individual moderator). If you do not give your
full name and affiliation, it may not be posted. Send
commands to subscribe/unsubscribe, get archives, help,
etc. to: majordomo@promedmail.org. For assistance from a
human being send mail to: owner-promed@promedmail.org.
################################################## ##########
################################################## ##########